[Medicamental immunosuppression in dermatology (author's transl)].
The pharmacology of the most important immunosuppressive agents in dermatology: glucocorticoids, azathioprine, cyclophosphamide, methotrexate and chlorambucil are reviewed. Our own results of treatment with these drugs (102 patients, diagnosis: lupus erythematosus, dermatomyositis, scleroderma, overlap-syndrome, pemphigus vulgaris, bullous pemphigoid, cryoglobulinaemic purpura, and pyoderma gangraenosum) are presented.
D001327:Autoimmune Diseases / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D010043:Outcome and Process Assessment, Health Care; D012871:Skin Diseases / Q000188:drug therapy*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate
Medikamentöse Immunsuppression in der Dermatologie.